Contact Us

Latest Developments and Insights

Blog Categories
Select Category
Blog Categories

Best Practices for System Evaluation and Selection

In order to maintain competitiveness, life science organizations are leveraging technology now more than ever to enhance decision-making, create innovative business models, and improve customer experiences. Many are considering the integration of new technology as a strategic move to streamline…

Read Full Article

NextGen Lab Moves: Strategies to Maximize Your Laboratory Relocation Plan

With a focus on people, process, and technology, Syner-G BioPharma Group empowers life science organizations with the knowledge and expertise needed to develop and execute their lab relocation strategies with confidence. By Jasmina Xie, Sr. Project Manager and Construction Manager,…

Read Full Article

The U.S.-China Trade War and Its Impacts on Investigational Drug Supply Chains

The ongoing U.S.-China trade war, now entering its seventh year, has evolved beyond tariffs into a broader strategic contest over technology, industrial policy, and national security. For the pharmaceutical sector — particularly the supply chains evolved to manufacture investigational drugs…

Read Full Article

Women’s History Month 2025

Sujata Kulkarni Why did you choose a career in biopharma? Growing up, I didn’t have the option to pursue medicine due to various reasons, so I had to select a field that aligned with my interests. This is when my…

Read Full Article

CFD Applications in Design of Manufacturing Processes and Facilities

Developing the manufacturing process can be one of the most time- and resource-intensive aspects of pharmaceutical development. Staying competitive requires leveraging cutting-edge tools that enhance efficiency, reduce costs, and improve overall process performance. One such tool is Computational Fluid Dynamics…

Read Full Article

Accelerating Cancer Treatment Approvals: The FDA’s Real-Time Oncology Review (RTOR) Program

In the ever-evolving landscape of cancer treatment, timely access to effective therapies is crucial. The FDA’s Real-Time Oncology Review (RTOR) program is a groundbreaking initiative designed to expedite the review process for oncology drugs and biologics ensuring that patients receive…

Read Full Article